Perioperative Continuation of Chronic Opioids and Buprenorphine-FREE NO CME

(1)

Create Account

Availability

On-Demand

Expires on Sep 29, 2028

Cost

$0.00

Credit Offered

No Credit Offered

Overview
Faculty
Accreditation
Additional Information

This monthly learning session addresses the complexities of managing patients on chronic opioid or buprenorphine therapy in the perioperative setting. Participants will explore the rationale behind continuing or adjusting these therapies during surgery, weighing the risks of withdrawal, inadequate pain relief, and drug interactions. The program will outline evidence-based protocols and strategies for managing these patients, encompassing pre-operative assessment, intraoperative adjustments, and tailored post-operative pain management plans. A key focus will be on the importance of interprofessional collaboration and communication, highlighting the need for seamless coordination between anesthesia providers, surgeons, pain specialists, and addiction specialists to ensure optimal patient outcomes.

Target Audience

Iowa Surgical providers
Clinical teams

Learning Objectives

Explain the rationale for continuing or adjusting chronic opioid and buprenorphine therapy in patients undergoing surgical procedures, considering the risks of opioid withdrawal, inadequate analgesia, and potential drug interactions.
Describe evidence-based protocols and strategies for managing patients on chronic opioid or buprenorphine therapy in the perioperative period, including pre-operative assessment, intraoperative adjustments, and post-operative pain management plans.
Discuss the importance of interprofessional collaboration and communication in caring for patients on chronic opioid or buprenorphine therapy undergoing surgery, including coordination between anesthesia providers, surgeons, pain specialists, and addiction specialists.

Rachael Duncan, PharmD BCPS BCCCP

Rachael is a pharmacist and consultant for Stader Opioid Consultants based in Colorado. She has spent the past eight years focused on policy, advocacy, and educational work surrounding harm reduction and substance use disorder treatment at both the state and national level. She serves on the board of directors for the nonprofit The Naloxone Project and is Co-Chair of the MOMs (Maternal Overdose Matters) Initiative, which helps birthing hospitals distribute naloxone directly to at-risk perinatal patients and families. She is also program director for MOMs+, which helps birthing hospitals provide equitable access to treatment and recovery for perinatal patients affected by substance use disorder. Her clinical practice is in hospital-based pharmacy.

No CME is available with this course. To access CME please register for the course titled Perioperative Continuation of Chronic Opioids and Buprenorphine-CME Paid Option

Fees are charged solely for individuals seeking Continuing Medical Education (CME) credits. All educational materials are provided at no cost and are freely accessible regardless of CME participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Compass is accredited by the IMS to provide continuing medical education for physicians.